Oaktree Acquisition Corp. III Life Sciences (OACCW) Total Liabilities (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences' Total Liabilities history runs 3 years deep, the most recent figure standing at $8.6 million for Q1 2026.

• Quarterly Total Liabilities rose 7.0% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (up 7.0% YoY) and the FY2025 annual result came in at $8.3 million, up 7.39% from the prior year.
• Total Liabilities was $8.6 million for Q1 2026 at Oaktree Acquisition Corp. III Life Sciences, up from $8.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $8.6 million in Q1 2026 and bottomed at $7.7 million in Q4 2024.
• A 3-year average of $8.2 million and a median of $8.2 million in 2025 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2025 — Total Liabilities climbed 7.39% — and 2026, when it gained 7.0%.
• Oaktree Acquisition Corp. III Life Sciences' Total Liabilities stood at $7.7 million in 2024, then gained by 7.39% to $8.3 million in 2025, then rose by 3.9% to $8.6 million in 2026.
• Business Quant data shows OACCW's Total Liabilities at $8.6 million in Q1 2026, $8.3 million in Q4 2025, and $8.2 million in Q3 2025.